Chargement en cours...
Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer
BACKGROUND: Personalized treatment for cancer patients is a hot topic of debate, particularly the decision to initiate chemotherapy in patients with Estrogen receptor (ER)-positive, HER2-negative tumors in the early stages of breast cancer (BC). Owing to significant advancements in information techn...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6034851/ https://ncbi.nlm.nih.gov/pubmed/29979736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0200100 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|